BlackRock Fund Advisors’s Anterix ATEX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
$8.67M Buy
384,491
+24,848
+7% +$600K ﹤0.01% 2650
2016
Q3
$8.24M Buy
359,643
+33,918
+10% +$758K ﹤0.01% 2578
2016
Q2
$6.97M Sell
325,725
-85,918
-21% -$2.71M ﹤0.01% 2617
2016
Q1
$14.1M Buy
411,643
+42,307
+11% +$1.12M ﹤0.01% 2178
2015
Q4
$10.2M Buy
369,336
+37,712
+11% +$1.03M ﹤0.01% 2435
2015
Q3
$9.92M Sell
331,624
-3,798
-1% -$124K ﹤0.01% 2372
2015
Q2
$14.1M Buy
+335,422
New +$15.8M ﹤0.01% 2314

Other funds holding ATEX

BlackRock Fund Advisors's ATEX Position: Q4 2016 in Review

BlackRock Fund Advisors increased its Anterix (ATEX) stake by 6.9% in Q4 2016, buying an estimated $600K and bringing the position to 384,491 shares worth $8.67M. The position accounts for ﹤0.01% of the portfolio, ranked #2650.

BlackRock Fund Advisors first reported a position in ATEX in Q2 2015 and has held it in 7 quarters since. The position peaked at $14.1M in Q1 2016. 55 funds tracked by Wall St. Rank hold ATEX as of Q4 2016.

  • BlackRock Fund Advisors held 384,491 shares of Anterix worth $8.67M as of Q4 2016.
  • BlackRock Fund Advisors bought 24,848 Anterix shares in Q4 2016, an estimated $600K.
  • Anterix made up ﹤0.01% of BlackRock Fund Advisors's portfolio in Q4 2016, its #2650 holding.
  • BlackRock Fund Advisors first reported a position in Anterix in Q2 2015 and has held it in 7 quarters since.
  • BlackRock Fund Advisors's Anterix position peaked at $14.1M in Q1 2016.
  • 55 funds tracked by Wall St. Rank held Anterix as of Q4 2016.

Based on BlackRock Fund Advisors's 13F filing for Q4 2016, filed 10 Feb 2017.